Noteworthy Read
Criminal Penalties Will Remain in Place Unless Marijuana Is Completely Descheduled (FAIR)
In a recent interview, Drug Policy Alliance’s Maritza Perez Medina emphasized that cannabis rescheduling does not remove it from the Controlled Substances Act or resolve federal criminal penalties. The discussion highlights the gap between medical recognition, commercial reform, and the unresolved legal consequences still facing cannabis consumers, workers, and people with prior convictions.
Read the article
View more in THC
More Noteworthy Reading
Trump Psychedelics Order Largely Symbolic, Analysts Say (The Guardian)
Analysts told The Guardian that a new executive order aimed at expanding access to psychedelic medicines may have limited legal effect, despite its framing around serious mental illness and veteran care. The order could make for a notable political signal, however, reflecting growing conservative interest in psychedelic research and drug-development pathways.
Read more
View more in Psychedelics
Cannabis Product Labels Often Inflate THC Potency (NORML)
A new analysis of cannabis products purchased from Colorado dispensaries found that labeled THC potency often exceeded independently tested values, especially for flower and edible products. The findings add to longstanding concerns that market incentives and inconsistent oversight are distorting consumer-facing potency claims.
Research Round-Up
Repeated Doses of Psilocybin Show Promise for Treating Obsessive-Compulsive Disorder (PsyPost)
A small clinical trial found that repeated psilocybin dosing was generally well-tolerated and associated with reduced obsessive-compulsive symptoms among adults with moderate to severe OCD. The preliminary results appear promising, with researchers noting the need for larger studies to clarify durability, dosing, and clinical utility.
Read more
View more in Psychedelics
CBD May Protect the Brain From Alzheimer’s by Activating a Hidden Repair Pathway (Earth.com)
New mouse research suggests CBD may help restore memory-related neural connections after Alzheimer’s-like damage has already appeared, potentially through a pathway tied to neuronal survival. The findings are preclinical, but they point to CBD as a possible option for more targeted brain therapies.
A heartfelt thank you to all of the CBD brands whose generous support fuels Project CBD’s mission to bring you the latest in plant medicine research and journalism — we couldn’t do it without you.
The post Project CBD Newsletter: Cannabis Rescheduling and Criminal Penalties, Trump’s Psychedelics Executive Order, THC Potency Mislabeling, Psilocybin for OCD, and CBD’s Potential Against Alzheimer’s appeared first on Project CBD.